CIK 0000886163
- Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770160744
- Phone
- +1 858-550-7500
- Business address
- 7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,384,247
- in 9 filings, $4.7M under 10b5-1 plans
Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-02-12 | Sharp John P VP Finance and CFO | Exercise or conversion | +6,086 | $10.05 | $61K | 23,753 |
| 2014-02-12 | Sharp John P VP Finance and CFO | Sale | −6,086 | $74.27 | $452K | 17,667 |
| 2014-02-12 | Sharp John P VP Finance and CFO | Exercise or conversion | +10,789 | $10.05 | $108K | 28,456 |
| 2014-02-12 | Sharp John P VP Finance and CFO | Sale | −10,789 | $75.73 | $817K | 17,667 |
| 2014-02-12 | Sharp John P VP Finance and CFO | Exercise or conversion | +2,879 | $14.47 | $42K | 20,546 |
| 2014-02-12 | Sharp John P VP Finance and CFO | Sale | −2,879 | $75.73 | $218K | 17,667 |
| 2014-02-12 | Sharp John P VP Finance and CFO | Exercise or conversion | +14,622 | $14.47 | $212K | 32,289 |
| 2014-02-12 | Sharp John P VP Finance and CFO | Sale | −14,622 | $74.27 | $1.1M | 17,667 |
| 2014-02-12 | Sharp John P VP Finance and CFO | Exercise or conversion | +4,584 | $21.92 | $100K | 22,251 |
| 2014-02-12 | Sharp John P VP Finance and CFO | Sale | −4,584 | $74.27 | $340K | 17,667 |
| 2014-02-12 | Sharp John P VP Finance and CFO | Exercise or conversion | +7,495 | $9.96 | $75K | 25,162 |
| 2014-02-12 | Sharp John P VP Finance and CFO | Sale | −7,495 | $74.27 | $557K | 17,667 |
| 2014-02-12 | Sharp John P VP Finance and CFO | Exercise or conversion · Incentive Stock Option (right to buy) | −10,789 | 13,125 | ||
| 2014-02-12 | Sharp John P VP Finance and CFO | Exercise or conversion · Incentive Stock Option (right to buy) | −2,879 | 8,917 | ||
| 2014-02-12 | Sharp John P VP Finance and CFO | Exercise or conversion · Incentive Stock Option (right to buy) | −16,666 | 0 | ||
| 2014-02-12 | Sharp John P VP Finance and CFO | Exercise or conversion · Incentive Stock Option (right to buy) | −7,321 | 6,012 | ||
| 2014-02-12 | Sharp John P VP Finance and CFO | Exercise or conversion · Incentive Stock Option (right to buy) | −6,012 | 0 | ||
| 2014-02-12 | Sharp John P VP Finance and CFO | Exercise or conversion · Incentive Stock Option (right to buy) | −8,333 | 0 | ||
| 2014-02-12 | Sharp John P VP Finance and CFO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −7,495 | 347 | ||
| 2014-02-12 | Sharp John P VP Finance and CFO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −6,086 | 0 |
Page 77 of 86 · 1,712 trades